BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 6826104)

  • 1. Relapse of antibiotic associated colitis: endogenous persistence of Clostridium difficile during vancomycin therapy.
    Walters BA; Roberts R; Stafford R; Seneviratne E
    Gut; 1983 Mar; 24(3):206-12. PubMed ID: 6826104
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clostridium difficile and cytotoxin in feces of patients with antimicrobial agent-associated pseudomembranous colitis.
    George WL; Rolfe RD; Harding GK; Klein R; Putnam CW; Finegold SM
    Infection; 1982; 10(4):205-8. PubMed ID: 7129642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibiotic-associated colitis caused by Clostridium difficile: relapse and risk factors.
    Young GP; Bayley N; Ward P; St John DJ; McDonald MI
    Med J Aust; 1986 Mar; 144(6):303-6. PubMed ID: 3520264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clostridium difficile colitis.
    Trnka YM; Lamont JT
    Adv Intern Med; 1984; 29():85-107. PubMed ID: 6369936
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapy of relapsing Clostridium difficile-associated diarrhea and colitis with the combination of vancomycin and rifampin.
    Buggy BP; Fekety R; Silva J
    J Clin Gastroenterol; 1987 Apr; 9(2):155-9. PubMed ID: 3571889
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Symptomatic relapse after oral vancomycin therapy of antibiotic-associated pseudomembranous colitis.
    Bartlett JG; Tedesco FJ; Shull S; Lowe B; Chang T
    Gastroenterology; 1980 Mar; 78(3):431-4. PubMed ID: 7053190
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Relapsing infections with Clostridium difficile].
    Visser WE; Dingemans-Dumas AM; Bac DJ
    Ned Tijdschr Geneeskd; 2005 Oct; 149(43):2381-5. PubMed ID: 16277125
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diarrhea we can treat: antibiotic-associated colitis.
    Levine HG; Lamont JT
    Compr Ther; 1982 Aug; 8(8):36-43. PubMed ID: 7128040
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Feacal carriage of cytotoxigenic strains of Clostridium difficile by adult Nigerians.
    Rotimi VO; Akindutire D
    East Afr Med J; 1989 May; 66(5):319-23. PubMed ID: 2791928
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recurrent pseudomembranous colitis unassociated with prior antibiotic therapy.
    Moskovitz M; Bartlett JG
    Arch Intern Med; 1981 Apr; 141(5):663-4. PubMed ID: 7224749
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pseudomembranous colitis: isolation of two species of cytotoxic clostridia and successful treatment with vancomycin.
    Marrie TJ; Faulkner RS; Badley BW; Hartlen MR; Comeau SA; Miller HR
    Can Med Assoc J; 1978 Nov; 119(9):1058-60. PubMed ID: 743667
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Enterocolitis caused by Clostridium difficile. Analysis of 15 cases in adults].
    Enzensberger R; Kipp J; Knothe H
    Dtsch Med Wochenschr; 1986 Jan; 111(2):56-9. PubMed ID: 3940837
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clostridium difficile colitis in leukemia patients.
    Panichi G; Pantosti A; Gentile G; Testore GP; Venditti M; Martino P; Serra P
    Eur J Cancer Clin Oncol; 1985 Oct; 21(10):1159-63. PubMed ID: 4076283
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Binding of Clostridium difficile cytotoxin and vancomycin by anion-exchange resins.
    Taylor NS; Bartlett JG
    J Infect Dis; 1980 Jan; 141(1):92-7. PubMed ID: 7365273
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapy of Clostridium difficile in pseudomembranous and antibiotic-associated colitis.
    Panichi G
    Chemioterapia; 1987 Jun; 6(2 Suppl):493-4. PubMed ID: 2978388
    [No Abstract]   [Full Text] [Related]  

  • 16. Recurrent refractory Clostridium difficile colitis treated successfully with rifaximin and tigecycline: a case report and review of the literature.
    El-Herte RI; Baban TA; Kanj SS
    Scand J Infect Dis; 2012 Mar; 44(3):228-30. PubMed ID: 22077098
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isolation rates and toxigenic potential of Clostridium difficile isolates from various patient populations.
    Viscidi R; Willey S; Bartlett JG
    Gastroenterology; 1981 Jul; 81(1):5-9. PubMed ID: 7239125
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of Clostridium difficile colitis. Summary of a round table held in Brussels on March, 3rd, 1994.
    Delmée M; Melin P; Peetermans W; Verbist L; Verschraegen G
    Acta Clin Belg; 1995; 50(2):114-6. PubMed ID: 7597874
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prospective randomised trial of metronidazole versus vancomycin for Clostridium-difficile-associated diarrhoea and colitis.
    Teasley DG; Gerding DN; Olson MM; Peterson LR; Gebhard RL; Schwartz MJ; Lee JT
    Lancet; 1983 Nov; 2(8358):1043-6. PubMed ID: 6138597
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The significance of quantitative results of C. difficile cultures and toxin assays in patients with diarrhea.
    Church JM; Fazio VW
    Dis Colon Rectum; 1985 Nov; 28(11):765-9. PubMed ID: 3902411
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.